Drugs / Potassium Gluconate

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1/2 NCT03563573 Comparator Jul → Nov 2018 attention deficit-hyperactivity disorder AlkaliDx, Inc. Unknown No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Potassium Gluconate ClinicalTrials.gov intervention name — accepted as the source's own label NCT03563573 ↗
Known as D-gluconic acid potassium salt ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as E-577 ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as Gluconic acid potassium salt ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as INS NO.577 ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as INS-577 ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as Kali gluconicum ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as Katorin ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as Monopotassium d-gluconate ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Known as Potassium d-gluconate ChEMBL registry synonym — accepted as the source's own label CHEMBL2106978 ↗
Modality Small molecule — CHEMBL2106978 ↗
Route Oral “Single-dose potassium gluconate oral capsule intervention for ADHD subjects for whom lidocaine is effective” NCT03563573 ↗